Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Current Opinion in Chemical Biology
|
March 18, 2011
Ligand specificity, privileged substructures and protein druggability from fragment-based screening
Sarah Barelier, Isabelle Krimm
Structure (London, England : 1993)
|
October 7, 2022
The long-awaited structure of human fucosidase FucA1 opens novel avenues for the treatment of fucosidosis
Sarah Barelier, Gerlind Sulzenbacher
ACS Chemical Biology
|
October 1, 2015
The Recognition of Identical Ligands by Unrelated Proteins
Sarah Barelier, Teague Sterling, Matthew J O'Meara, et al.
Journal of Medicinal Chemistry
|
June 26, 2010
Ligand specificity in fragment-based drug design
Sarah Barelier, Julien Pons, Kalle Gehring, et al.
Journal of Medicinal Chemistry
|
March 3, 2010
Fragment-based deconstruction of Bcl-xL inhibitors
Sarah Barelier, Julien Pons, Olivier Marcillat, et al.
Biochemical and Biophysical Research Communications
|
August 31, 2010
The role of the glycine triad in human glutathione synthetase
Adriana Dinescu, Teresa R Brown, Sarah Barelier, et al.
Nucleic Acids Research
|
April 30, 2024
ChemoDOTS: a web server to design chemistry-driven focused libraries
Laurent Hoffer, Guillaume Charifi-Hoareau, Sarah Barelier, et al.
Plos One
|
July 23, 2013
Roles for ordered and bulk solvent in ligand recognition and docking in two related cavities
Sarah Barelier, Sarah E Boyce, Inbar Fish, et al.
Plos One
|
March 23, 2010
Discovery of fragment molecules that bind the human peroxiredoxin 5 active site
Sarah Barelier, Dominique Linard, Julien Pons, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2012
Fragment-guided design of subnanomolar β-lactamase inhibitors active in vivo
Oliv Eidam, Chiara Romagnoli, Guillaume Dalmasso, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Current Opinion in Chemical Biology
|
March 18, 2011
Ligand specificity, privileged substructures and protein druggability from fragment-based screening
Sarah Barelier, Isabelle Krimm
Structure (London, England : 1993)
|
October 7, 2022
The long-awaited structure of human fucosidase FucA1 opens novel avenues for the treatment of fucosidosis
Sarah Barelier, Gerlind Sulzenbacher
ACS Chemical Biology
|
October 1, 2015
The Recognition of Identical Ligands by Unrelated Proteins
Sarah Barelier, Teague Sterling, Matthew J O'Meara, et al.
Journal of Medicinal Chemistry
|
June 26, 2010
Ligand specificity in fragment-based drug design
Sarah Barelier, Julien Pons, Kalle Gehring, et al.
Journal of Medicinal Chemistry
|
March 3, 2010
Fragment-based deconstruction of Bcl-xL inhibitors
Sarah Barelier, Julien Pons, Olivier Marcillat, et al.
Biochemical and Biophysical Research Communications
|
August 31, 2010
The role of the glycine triad in human glutathione synthetase
Adriana Dinescu, Teresa R Brown, Sarah Barelier, et al.
Nucleic Acids Research
|
April 30, 2024
ChemoDOTS: a web server to design chemistry-driven focused libraries
Laurent Hoffer, Guillaume Charifi-Hoareau, Sarah Barelier, et al.
Plos One
|
July 23, 2013
Roles for ordered and bulk solvent in ligand recognition and docking in two related cavities
Sarah Barelier, Sarah E Boyce, Inbar Fish, et al.
Plos One
|
March 23, 2010
Discovery of fragment molecules that bind the human peroxiredoxin 5 active site
Sarah Barelier, Dominique Linard, Julien Pons, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2012
Fragment-guided design of subnanomolar β-lactamase inhibitors active in vivo
Oliv Eidam, Chiara Romagnoli, Guillaume Dalmasso, et al.
Page
of 2